Thrombopoietin Receptor (TPO)

Eltrombopag is an agonist of the Thrombopoietin (Tpo) receptor, used as treatment for thrombocytopenia.

Megakaryocytes/platelets inducing agent is an inducing agent for megakaryocytes and/or platelets from pluripotent stem cells, the inducing agent being useful in treating diseases involving thrombopenia.

Avatrombopag is a novel orally-active thrombopoietin (TPO) receptor agonist.

Eltrombopag olamine is a new, orally active thrombopoietin-receptor (c-mpl) agonist that stimulates thrombopoiesis.

TPO agonist 1 can increase production of platelets by stimulating the TPO receptor in people with chronic ITP.

Lusutrombopag, also known as S-888711, is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist being developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery.

Thrombopoietin Human Recombinant, HEK

Thrombopoietin Human Recombinant

Thrombopoietin Mouse Recombinant

ThrombopoietinHuman Recombinant, His Tag